Home › Research › Topics › convolutional
convolutional
205 studies tagged convolutional, dated 2006-12-06 to 2026-10-30. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Tau-CTFP: A connectome-informed continuous-time first-passage model for forecasting the onset of regional tau PET abnormality 2026-10-30
- A Wasserstein Weisfeiler-Lehman Kernel Framework for Multimodal Brain Connectome Analysis 2026-10-29
- Current gaps in downstream applications of fMRI foundation models: lessons learned from BrainLM & BrainHarmonix on Prevent-AD 2026-10-26
Studies
205 studies carry this tag.
Date range
2006 to 2026
Top journals
- Research Square 22
- medRxiv 22
- NeuroImage 14
- bioRxiv 14
- Preprints.org 7
87 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Neuropathologists assess vast brain areas to identify diverse and subtly-differentiated morphologies.
-
57/100
The increasing application of Artificial Intelligence (AI) in health and medicine has attracted a great deal of research interest in recent decades.
-
Overall, the application of ML to mental health has demonstrated a range of benefits across the areas of diagnosis, treatment and support, research, and clinical administration.
-
A World Health Organization (WHO) Feb 2018 report has recently shown that mortality rate due to brain or central nervous system (CNS) cancer is the highest in the Asian continent.
-
43/100
Alzheimer's disease (AD) is one of the most common progressive and irreversible neurodegenerative diseases.
-
Structural magnetic resonance imaging (sMRI) has been widely used for computer-aided diagnosis of neurodegenerative disorders, e.g., Alzheimer's disease (AD), due to its sensitivity to morphological changes caused by brain atrophy.
-
We built and validated a deep learning algorithm predicting the individual diagnosis of Alzheimer's disease (AD) and mild cognitive impairment who will convert to AD (c-MCI) based on a single cross-sectional brain structural MRI scan.
-
Alzheimer's Disease (AD) is characterized by a cascade of biomarkers becoming abnormal, the pathophysiology of which is very complex and largely unknown.
-
We developed a robust algorithm to automatically evaluate retinal fundus image that can identify subjects with high WMH burden.
-
48/100
By using fluorine 18 fluorodeoxyglucose PET of the brain, a deep learning algorithm developed for early prediction of Alzheimer disease achieved 82% specificity at 100% sensitivity, an average of 75.8 months prior to the final diagnosis. © RSNA, 2018 Online supplemental material is available for this article.
-
Mild cognitive impairment (MCI) is the prodromal stage of Alzheimer's disease (AD).
-
Accurate and early diagnosis of Alzheimer's disease (AD) plays important role for patient care and development of future treatment.
-
In the field of computer-aided Alzheimer's disease (AD) diagnosis, jointly identifying brain diseases and predicting clinical scores using magnetic resonance imaging (MRI) have attracted increasing attention since these two tasks are highly correlated.
-
In this paper, we provide an extensive overview of machine learning techniques applied to structural magnetic resonance imaging (MRI) data to obtain clinical classifiers.
-
Alzheimer's disease (AD) is an irreversible brain degenerative disorder affecting people aged older than 65 years.
-
Graphs are widely used as a natural framework that captures interactions between individual elements represented as nodes in a graph.
-
Alzheimer's disease is an incurable, progressive neurological brain disorder.
-
Accurate spatial normalization (SN) of amyloid positron emission tomography (PET) images for Alzheimer's disease assessment without coregistered anatomical magnetic resonance imaging (MRI) of the same individual is technically challenging.
-
Alzheimer's Disease (AD) is a progressive neurodegenerative disease where biomarkers for disease based on pathophysiology may be able to provide objective measures for disease diagnosis and staging.
-
Alzheimer's disease (AD) is a progressive brain disease.
-
For effective treatment of Alzheimer's disease (AD), it is important to identify subjects who are most likely to exhibit rapid cognitive decline.
-
Recently, transfer learning has been successfully applied in early diagnosis of Alzheimer's Disease (AD) based on multi-domain data.
-
41/100
Using subset of optimal features in SVM, we classified MCI-C from MCI-NC with an accuracy, sensitivity, specificity, and the area under the receiver operating characteristic (ROC) curve of 91.4%, 83.24%, 90.1%, and 0.95, respectively.
-
Recent studies on brain imaging analysis witnessed the core roles of machine learning techniques in computer-assisted intervention for brain disease diagnosis.
-
The accurate diagnosis of Alzheimer's disease (AD) and its early stage, i.e., mild cognitive impairment, is essential for timely treatment and possible delay of AD.
-
While computerised tomography (CT) may have been the first imaging tool to study human brain, it has not yet been implemented into clinical decision making process for diagnosis of Alzheimer's disease (AD).
-
Computer Aided Diagnosis (CAD) constitutes an important tool for the early diagnosis of Alzheimer's Disease (AD), which, in turn, allows the application of treatments that can be simpler and more likely to be effective.
-
Neuroimaging-based single subject prediction of brain disorders has gained increasing attention in recent years.
-
Modern machine learning and linguistic analysis will be increasingly useful in assessment and clustering of suspected AD.
-
EEG characteristics that correlate with the cognitive functions are important in detecting mild cognitive impairment (MCI) in T2DM.
-
Multivariate pattern analysis and statistical machine learning techniques are attracting increasing interest from the neuroimaging community.
-
Alzheimer's disease (AD) patients exhibit alterations in the functional connectivity between spatially segregated brain regions which may be related to both local gray matter (GM) atrophy as well as a decline in the fiber integrity of the underlying white matter tracts.
-
The accurate diagnosis of Alzheimer's disease (AD) is essential for patient care and will be increasingly important as disease modifying agents become available, early in the course of the disease.
-
36/100
Mild cognitive impairment (MCI) is a transitional stage between age-related cognitive decline and Alzheimer's disease (AD).
-
40/100
For the last decade, it has been shown that neuroimaging can be a potential tool for the diagnosis of Alzheimer's Disease (AD) and its prodromal stage, Mild Cognitive Impairment (MCI), and also fusion of different modalities can further provide the complementary information to enhance diagnostic accuracy.
-
48/100
Nonrigid image registration is an important, but time-consuming task in medical image analysis.
-
Combining multi-modality brain data for disease diagnosis commonly leads to improved performance.
-
Machine learning algorithms and multivariate data analysis methods have been widely utilized in the field of Alzheimer's disease (AD) research in recent years.
-
Recently, there have been great interests for computer-aided diagnosis of Alzheimer's disease (AD) and its prodromal stage, mild cognitive impairment (MCI).
-
Accurately identifying the patients that have mild cognitive impairment (MCI) who will go on to develop Alzheimer's disease (AD) will become essential as new treatments will require identification of AD patients at earlier stages in the disease process.
-
In recent years, there has been a great interest in computer-aided diagnosis of Alzheimer's Disease (AD) and its prodromal stage, Mild Cognitive Impairment (MCI).
-
36/100
Neurodegenerative disorders, such as Alzheimer's disease, are associated with changes in multiple neuroimaging and biological measures.
-
Standard univariate analysis of neuroimaging data has revealed a host of neuroanatomical and functional differences between healthy individuals and patients suffering a wide range of neurological and psychiatric disorders.
-
There are growing numbers of studies using machine learning approaches to characterize patterns of anatomical difference discernible from neuroimaging data.
-
Many machine learning and pattern classification methods have been applied to the diagnosis of Alzheimer's disease (AD) and its prodromal stage, i.e., mild cognitive impairment (MCI).
-
Brain extraction is an important step in the analysis of brain images.
-
However, most existing research focuses on only a single modality of biomarkers for diagnosis of AD and MCI, although recent studies have shown that different biomarkers may provide complementary information for the diagnosis of AD and MCI.
-
This paper reviews recent progress in the diagnosis of Alzheimer's disease (AD) from electroencephalograms (EEG).
-
A new chaos-wavelet approach is presented for electroencephalogram (EEG)-based diagnosis of Alzheimer's disease (AD) employing a recently developed concept in graph theory, visibility graph (VG).
-
Recently, several high dimensional classification methods have been proposed to automatically discriminate between patients with Alzheimer's disease (AD) or mild cognitive impairment (MCI) and elderly controls (CN) based on T1-weighted MRI.
From across this tag
7 of the 205 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 7. The same 7 appear here every time.
- AD-BERT: Using pre-trained language model to predict the progression from mild cognitive impairment to Alzheimer's disease
- Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly
- Organ aging signatures in the plasma proteome track health and disease
- Interpretable Frequency-Aware Deep Learning for Multi-Class EEG Classification of Neurological Disorders
- Visual interpretation of [18F]Florbetaben PET supported by deep learning-based estimation of amyloid burden
- Application and comparison of classification algorithms for recognition of Alzheimer's disease in electrical brain activity (EEG)
- Deep residual inception encoder-decoder network for amyloid PET harmonization